blood tests for identifying and monitoring alk-positive non-small cell lung cancer
Published 8 years ago • 240 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
2:05
assess trial: blood test for egfr mutation in advanced non-small cell lung cancer
-
1:01
targeting alk rearrangements in non-small cell lung cancer
-
2:00
updated data from phase 2 study of alectinib in alk–positive non–small–cell lung cancer
-
4:36
blood first assay screening in patients with alk positive nsclc
-
3:53
how to maximize clinical benefits for patients with alk-positive non-small cell lung cancer
-
9:00
fda d.i.s.c.o.: two approvals for alk-positive non-small cell lung cancer
-
0:58
progress in the treatment of alk-positive non-small cell lung cancer
-
0:56
nautika1: safety and tolerability of neoadjuvant alectinib in alk-positive nsclc
-
3:24
antibodies against non small cell lung cancer (alk)
-
1:25
updates and unmet needs in alk-mutated lung cancer
-
9:43
alk positive forum testing
-
4:31
emerging applications of liquid biopsy in non-small-cell lung cancer
-
4:50
pennell new options in acquired resistance for alk positive non-small cell lung cancer (nsclc)
-
3:34
alk-positive nsclc: the role of treatment selection and sequencing
-
2:09
biomarker guidelines for non-small cell lung cancer
-
1:47
alk rearrangements: what are they, and who has them?
-
1:24
choosing the best alk inhibitor for lung cancer
-
0:52
genomic testing is necessary in non-small cell lung cancer
-
49:54
practical principles of biomarker testing in advanced non-small cell lung cancer